US Stock MarketDetailed Quotes

FibroBiologics (FBLG)

Watchlist
  • 1.420
  • -0.090-5.96%
Close Apr 24 16:00 ET
  • 1.410
  • -0.010-0.70%
Post 19:56 ET
6.45MMarket Cap-0.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

FibroBiologics (FBLG) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
21.20%16.65M
-30.23%2.59M
50.30%5.04M
39.27%4.49M
31.33%4.53M
54.54%13.74M
49.68%3.71M
63.35%3.35M
54.04%3.22M
52.32%3.45M
Selling and administrative expenses
0.10%9.24M
-23.90%1.79M
5.14%2.25M
8.89%2.45M
10.48%2.75M
41.59%9.23M
38.02%2.36M
44.43%2.14M
45.47%2.25M
39.34%2.49M
-General and administrative expense
0.10%9.24M
-23.90%1.79M
5.14%2.25M
8.89%2.45M
10.48%2.75M
41.59%9.23M
38.02%2.36M
44.43%2.14M
45.47%2.25M
39.34%2.49M
Research and development costs
64.45%7.41M
-41.22%797K
129.93%2.79M
109.33%2.04M
85.42%1.78M
90.20%4.5M
75.42%1.36M
112.43%1.21M
78.24%975K
100.84%960K
Operating profit
-21.20%-16.65M
30.23%-2.59M
-50.30%-5.04M
-39.27%-4.49M
-31.33%-4.53M
-54.54%-13.74M
-49.68%-3.71M
-63.35%-3.35M
-54.04%-3.22M
-52.32%-3.45M
Net non-operating interest income expense
-81.39%43K
-414.04%-179K
-1.35%73K
-23.08%50K
182.86%99K
257.14%231K
5,800.00%57K
74K
750.00%65K
125.93%35K
Non-operating interest income
-1.59%247K
-60.32%25K
-7.59%73K
-28.57%50K
153.85%99K
--251K
--63K
--79K
--70K
--39K
Non-operating interest expense
920.00%204K
3,300.00%204K
--0
--0
--0
-86.39%20K
500.00%6K
--5K
-50.00%5K
-97.04%4K
Other net income (expense)
-186.99%-2.04M
-185.43%-475K
-129.27%-813K
-105.37%-218K
89.42%-534K
131.48%2.35M
107.68%556K
2,070.21%2.78M
7,217.54%4.06M
-33,533.33%-5.05M
Gain on sale of security
-93.85%352K
-83.74%329K
-98.81%33K
-98.19%73K
---83K
179.08%5.72M
--2.02M
--2.78M
--4.03M
----
Other non- operating income (expenses)
29.17%-2.39M
45.19%-804K
-42,400.00%-846K
-1,070.00%-291K
91.06%-451K
-1,485.45%-3.38M
---1.47M
101.42%2K
152.63%30K
-33,533.33%-5.05M
Income before tax
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
-250.31%-8.46M
Income tax
Net income
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
-250.31%-8.46M
Net income continuous Operations
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
-250.31%-8.46M
Minority interest income
Net income attributable to the parent company
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
-250.31%-8.46M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
Net income attributable to common stockholders
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
41.44%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
-69.61%-8.46M
Basic earnings per share
-23.53%-8.4
66.67%-0.6
-1,200.00%-2.6
-500.00%-2.4
48.15%-2.8
42.06%-6.8
69.92%-1.8
85.19%-0.2
145.11%0.6
-75.80%-5.4
Diluted earnings per share
-23.53%-8.4
66.67%-0.6
-1,200.00%-2.6
-500.00%-2.4
48.15%-2.8
42.06%-6.8
69.92%-1.8
85.19%-0.2
145.11%0.6
-75.80%-5.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 21.20%16.65M-30.23%2.59M50.30%5.04M39.27%4.49M31.33%4.53M54.54%13.74M49.68%3.71M63.35%3.35M54.04%3.22M52.32%3.45M
Selling and administrative expenses 0.10%9.24M-23.90%1.79M5.14%2.25M8.89%2.45M10.48%2.75M41.59%9.23M38.02%2.36M44.43%2.14M45.47%2.25M39.34%2.49M
-General and administrative expense 0.10%9.24M-23.90%1.79M5.14%2.25M8.89%2.45M10.48%2.75M41.59%9.23M38.02%2.36M44.43%2.14M45.47%2.25M39.34%2.49M
Research and development costs 64.45%7.41M-41.22%797K129.93%2.79M109.33%2.04M85.42%1.78M90.20%4.5M75.42%1.36M112.43%1.21M78.24%975K100.84%960K
Operating profit -21.20%-16.65M30.23%-2.59M-50.30%-5.04M-39.27%-4.49M-31.33%-4.53M-54.54%-13.74M-49.68%-3.71M-63.35%-3.35M-54.04%-3.22M-52.32%-3.45M
Net non-operating interest income expense -81.39%43K-414.04%-179K-1.35%73K-23.08%50K182.86%99K257.14%231K5,800.00%57K74K750.00%65K125.93%35K
Non-operating interest income -1.59%247K-60.32%25K-7.59%73K-28.57%50K153.85%99K--251K--63K--79K--70K--39K
Non-operating interest expense 920.00%204K3,300.00%204K--0--0--0-86.39%20K500.00%6K--5K-50.00%5K-97.04%4K
Other net income (expense) -186.99%-2.04M-185.43%-475K-129.27%-813K-105.37%-218K89.42%-534K131.48%2.35M107.68%556K2,070.21%2.78M7,217.54%4.06M-33,533.33%-5.05M
Gain on sale of security -93.85%352K-83.74%329K-98.81%33K-98.19%73K---83K179.08%5.72M--2.02M--2.78M--4.03M----
Other non- operating income (expenses) 29.17%-2.39M45.19%-804K-42,400.00%-846K-1,070.00%-291K91.06%-451K-1,485.45%-3.38M---1.47M101.42%2K152.63%30K-33,533.33%-5.05M
Income before tax -67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K-250.31%-8.46M
Income tax
Net income -67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K-250.31%-8.46M
Net income continuous Operations -67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K-250.31%-8.46M
Minority interest income
Net income attributable to the parent company -67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K-250.31%-8.46M
Preferred stock dividends
Other preferred stock dividends 00000
Net income attributable to common stockholders -67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M41.44%-11.16M68.11%-3.1M77.20%-500K141.57%898K-69.61%-8.46M
Basic earnings per share -23.53%-8.466.67%-0.6-1,200.00%-2.6-500.00%-2.448.15%-2.842.06%-6.869.92%-1.885.19%-0.2145.11%0.6-75.80%-5.4
Diluted earnings per share -23.53%-8.466.67%-0.6-1,200.00%-2.6-500.00%-2.448.15%-2.842.06%-6.869.92%-1.885.19%-0.2145.11%0.6-75.80%-5.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -